Terms: = Pancreatic cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
28 results:
1. Determination of ERG(+), EZH2, NKX3.1, and SPINK-1 subtypes to evaluate their association with clonal origin and disease progression in multifocal prostate cancer.
Segura-Moreno YY; Sanabria-Salas MC; Mesa-López De Mesa JA; Varela-Ramirez R; Acosta-Vega NL; Serrano ML
Cancer Rep (Hoboken); 2023 Feb; 6(2):e1728. PubMed ID: 36199157
[TBL] [Abstract] [Full Text] [Related]
2. Generalized methodology for radiomic feature selection and modeling in predicting clinical outcomes.
Yang J; Xu L; Yang P; Wan Y; Luo C; Yen EA; Lu Y; Chen F; Lu Z; Rong Y; Niu T
Phys Med Biol; 2021 Oct; 66(21):. PubMed ID: 34633308
[No Abstract] [Full Text] [Related]
3. The endogenous cellular protease inhibitor SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.
Ramirez Alvarez C; Kee C; Sharma AK; Thomas L; Schmidt FI; Stanifer ML; Boulant S; Herrmann C
PLoS Pathog; 2021 Jun; 17(6):e1009687. PubMed ID: 34181691
[TBL] [Abstract] [Full Text] [Related]
4. SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment.
Wu CT; Lidsky PV; Xiao Y; Lee IT; Cheng R; Nakayama T; Jiang S; Demeter J; Bevacqua RJ; Chang CA; Whitener RL; Stalder AK; Zhu B; Chen H; Goltsev Y; Tzankov A; Nayak JV; Nolan GP; Matter MS; Andino R; Jackson PK
Cell Metab; 2021 Aug; 33(8):1565-1576.e5. PubMed ID: 34081912
[TBL] [Abstract] [Full Text] [Related]
5. Immune Interaction Map of Human SARS-CoV-2 Target Genes: Implications for Therapeutic Avenues.
Subbarayan K; Ulagappan K; Wickenhauser C; Bachmann M; Seliger B
Front Immunol; 2021; 12():597399. PubMed ID: 33796097
[TBL] [Abstract] [Full Text] [Related]
6. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
Katopodis P; Kerslake R; Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Anikin V; Polychronis A; Robertus JL; Kyrou I; Karteris E
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649798
[TBL] [Abstract] [Full Text] [Related]
7. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract.
Lee JJ; Kopetz S; Vilar E; Shen JP; Chen K; Maitra A
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32545271
[TBL] [Abstract] [Full Text] [Related]
8. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
[TBL] [Abstract] [Full Text] [Related]
9. Prostate cancer Risk Stratification in Men With a Clinical Suspicion of Prostate cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques.
Montoya Perez I; Jambor I; Pahikkala T; Airola A; Merisaari H; Saunavaara J; Alinezhad S; Väänänen RM; Tallgrén T; Verho J; Kiviniemi A; Ettala O; Knaapila J; Syvänen KT; Kallajoki M; Vainio P; Aronen HJ; Pettersson K; Boström PJ; Taimen P
J Magn Reson Imaging; 2020 May; 51(5):1540-1553. PubMed ID: 31588660
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of ERG and SPINK1 expression among incidental and metastatic prostate cancer in Japanese men.
Koide H; Kimura T; Inaba H; Sato S; Iwatani K; Yorozu T; Furusato B; Kamata Y; Miki J; Kiyota H; Takahashi H; Egawa S
Prostate; 2019 Jan; 79(1):3-8. PubMed ID: 30051483
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis.
Ma KW; Chan ACY; She WH; Chok KSH; Dai WC; Tsang S; Cheung TT; Lo CM
Surg Endosc; 2018 Feb; 32(2):971-976. PubMed ID: 28779260
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Discriminators of Racial Disparities in Prostate cancer.
Ateeq B; Bhatia V; Goel S
Trends Cancer; 2016 Mar; 2(3):116-120. PubMed ID: 28741531
[TBL] [Abstract] [Full Text] [Related]
13. Racial Variations in Prostate cancer Molecular Subtypes and Androgen Receptor Signaling Reflect Anatomic Tumor Location.
Faisal FA; Sundi D; Tosoian JJ; Choeurng V; Alshalalfa M; Ross AE; Klein E; Den R; Dicker A; Erho N; Davicioni E; Lotan TL; Schaeffer EM
Eur Urol; 2016 Jul; 70(1):14-17. PubMed ID: 26443432
[TBL] [Abstract] [Full Text] [Related]
14. The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap.
Klimstra DS; Beltran H; Lilenbaum R; Bergsland E
Am Soc Clin Oncol Educ Book; 2015; ():92-103. PubMed ID: 25993147
[TBL] [Abstract] [Full Text] [Related]
15. Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India.
Ateeq B; Kunju LP; Carskadon SL; Pandey SK; Singh G; Pradeep I; Tandon V; Singhai A; Goel A; Amit S; Agarwal A; Dinda AK; Seth A; Tsodikov A; Chinnaiyan AM; Palanisamy N
Prostate; 2015 Jul; 75(10):1051-62. PubMed ID: 25809148
[TBL] [Abstract] [Full Text] [Related]
16. Molecular foundations for personalized therapy in prostate cancer.
Fisher KW; Montironi R; Lopez Beltran A; Moch H; Wang L; Scarpelli M; Williamson SR; Koch MO; Cheng L
Curr Drug Targets; 2015; 16(2):103-14. PubMed ID: 25547910
[TBL] [Abstract] [Full Text] [Related]
17. Expression profile of MAGI2 gene as a novel biomarker in combination with major deregulated genes in prostate cancer.
Mahdian R; Nodouzi V; Asgari M; Rezaie M; Alizadeh J; Yousefi B; Shahrokh H; Abolhasani M; Nowroozi M
Mol Biol Rep; 2014 Sep; 41(9):6125-31. PubMed ID: 24985972
[TBL] [Abstract] [Full Text] [Related]
18. SPINK1 protein expression and prostate cancer progression.
Flavin R; Pettersson A; Hendrickson WK; Fiorentino M; Finn S; Kunz L; Judson GL; Lis R; Bailey D; Fiore C; Nuttall E; Martin NE; Stack E; Penney KL; Rider JR; Sinnott J; Sweeney C; Sesso HD; Fall K; Giovannucci E; Kantoff P; Stampfer M; Loda M; Mucci LA
Clin Cancer Res; 2014 Sep; 20(18):4904-11. PubMed ID: 24687926
[TBL] [Abstract] [Full Text] [Related]
19. cancer-associated changes in the expression of tmprss2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens.
Väänänen RM; Lilja H; Kauko L; Helo P; Kekki H; Cronin AM; Vickers AJ; Nurmi M; Alanen K; Bjartell A; Pettersson K
Urology; 2014 Feb; 83(2):511.e1-7. PubMed ID: 24468524
[TBL] [Abstract] [Full Text] [Related]
20. A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
Lippolis G; Edsjö A; Stenman UH; Bjartell A
Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):145-50. PubMed ID: 23459095
[TBL] [Abstract] [Full Text] [Related]
[Next]
